Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

My body, my property.

L B Andrews

    The Hastings Center Report
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Should human body parts be property? Current research uses patient tissues without consent or profit sharing. A regulated market could ensure fair compensation and patient control over their biological materials.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Implementation of a pharmacist-driven pain management consultation service for hospitalised adults with a history of substance abuse.

    International journal of clinical practice·2013
    Same author

    A conceptual framework for genetic policy: comparing the medical, public health, and fundamental rights models.

    Washington University law quarterly. Washington University (Saint Louis, Mo.). School of Law·2005
    Same author

    Human cloning: assessing the ethical and legal questions.

    The Chronicle of higher education·2003
    Same author

    Whose genes are they anyway?

    The Chronicle of higher education·2003
    Same author

    Is there a right to clone? Constitutional challenges to bans on human cloning.

    Harvard journal of law & technology·2003
    Same author

    Reproductive technology comes of age.

    Whittier law review·2002
    Same journal

    Harm Reduction as an Alternative to Mandated Drug Treatment.

    The Hastings Center report·2026
    Same journal

    Rethinking Mandated Drug Treatment: Why Expanding Freedom Requires Structural Drug Policy Reform.

    The Hastings Center report·2026
    Same journal

    Banning Gender-Affirming Treatment for Minors: The Supreme Court Speaks.

    The Hastings Center report·2026
    Same journal

    Making the Move to a Learning System of Research Ethics.

    The Hastings Center report·2026
    Same journal

    Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions.

    The Hastings Center report·2026
    Same journal

    Transformed but Not Cured: The Ethics of Describing Gene-Editing Therapy for Sickle Cell Disease.

    The Hastings Center report·2026
    See all related articles

    Area of Science:

    • Bioethics
    • Medical Law
    • Property Law

    Background:

    • Current medical research often utilizes patient-derived biological materials without explicit consent or profit sharing.
    • Existing policies do not adequately address patient rights concerning the commercialization of research derived from their body parts.

    Purpose of the Study:

    • To explore the ethical and legal implications of considering human body parts as property.
    • To examine the potential benefits and drawbacks of establishing a market for body parts and products.
    • To propose a framework for patient consent, fair compensation, and control in biological material research.

    Main Methods:

    • Analysis of recent legal cases concerning patient-derived biological materials.
    • Review of existing ethical guidelines and property law principles.
    Keywords:
    Analytical ApproachBiomedical and Behavioral ResearchHealth Care and Public HealthLegal ApproachProfessional Patient Relationship

    Related Experiment Videos

  • Discussion of potential market models for body parts and products.

    • Main Results:

    • Patients currently lack control and compensation for research applications of their body parts.
    • A regulated market could necessitate consent for all research categories and protect against exploitation.
    • Revisiting organ sale prohibitions may be warranted under a controlled market system.

    Conclusions:

    • Establishing a market for body parts, with clear ownership and control retained by individuals, could benefit donors, recipients, and society.
    • Patient consent and fair remuneration are crucial for ethical engagement with biological materials in research.
    • Rethinking current policies on organ sales and biological material commercialization is necessary.